NCT03531697View on ClinicalTrials.gov

Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery

PHASE1CompletedINTERVENTIONAL

Enrollment

381

Participants

Timeline

Start Date

April 26, 2018

Primary Completion Date

September 7, 2019

Study Completion Date

October 7, 2019

Conditions

Inflammation Following Ocular Surgery

Interventions

DRUG

Generic Loteprednol Etabonate

Drug

DRUG

Reference Listed Drug (RLD)

Drug

Trial Locations (1)

Unknown

Sandoz Investigative Site, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sandoz

INDUSTRY